Similar articles

• Alternative methods for analysis of radiographic damage in a randomized, double blind, parallel group clinical trial comparing hydroxychloroquine and sulfasalazine.

  van der Heijde DM, van Riel PL, Nuver-Zwart IH, van de Putte LB. van der Heijde DM, et al. J Rheumatol. 2000 Feb;27(2):535-8; discussion 538-9. J Rheumatol. 2000. PMID: 10685829 Clinical Trial.
• How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine?

  Dixon JS, Greenwood M, Bird HA. Dixon JS, et al. Clin Rheumatol. 1988 Jun;7(2):262-6. doi: 10.1007/BF02204465. Clin Rheumatol. 1988. PMID: 2901304
• Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.

  Clegg DO, Ward JR. Clegg DO, et al. Nurse Pract. 1987 Mar;12(3):44, 49-52. Nurse Pract. 1987. PMID: 2882451
• Rheumatoid arthritis: can the long-term outcome be altered?

  Gabriel SE, Luthra HS. Gabriel SE, et al. Mayo Clin Proc. 1988 Jan;63(1):58-68. doi: 10.1016/s0025-6196(12)62665-2. Mayo Clin Proc. 1988. PMID: 3275843 Review.
• Rheumatoid arthritis.

  Emery P, Suarez-Almazor M. Emery P, et al. Clin Evid. 2003 Jun;(9):1349-71. Clin Evid. 2003. PMID: 15366179 Review. No abstract available.